Dynatronics

Dynatronics EBITDA Margin

Delisted

The EBITDA Margin of Dynatronics (DYNT) as of Nov 5, 2026 is -8.44 %. In the previous year, EBITDA Margin was -6.57 % — a change of 28.30% (lower).

EBITDA Margin

-8.44 %

YoY

28.30%

Last updated:

EBITDA Margin of Dynatronics is 2025 -8.44 % . EBITDA Margin of Dynatronics was 2024 -6.57 % . It decreases by 28.30% lower compared to the previous year.

The Dynatronics EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2018
-1.93 USD
Jan 1, 2019
-1.27 USD
Jan 1, 2020
-5.24 USD
Jan 1, 2021
5.04 USD
Jan 1, 2022
-9.97 USD
Jan 1, 2023
-11.53 USD
Jan 1, 2024
-6.57 USD
Jan 1, 2025
-8.44 USD
The Dynatronics EBITDA Margin history
YEAREBITDA MarginYoY
-8.44 %+28.30%
-6.57 %-42.97%
-11.53 %+15.67%
-9.97 %-297.93%
5.04 %-196.07%
-5.24 %+311.97%
-1.27 %-34.13%
-1.93 %-58.75%
-4.68 %-15.26%
-5.53 %+48.04%
-3.73 %+451.40%
-0.68 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dynatronics Stock analysis

What does Dynatronics do? Dynatronics Corp generates revenue through the sale of medical equipment and supplies for physical therapy and rehabilitation. The company offers therapeutic modalities like Dynatron Solaris for electrotherapy and thermal therapy, and the 25 Series for electrotherapy and ultrasound. It also sells manufactured capital products such as traction systems and wood furniture, along with distributed capital products including hydrotherapy and weight training equipment. Physical therapists, chiropractors, sports medicine practitioners, podiatrists, and physicians purchase these products for use in their practices. The firm's product portfolio includes manufactured supplies like cold packs, straps, wedges, bolsters, and mats, as well as distributed supplies such as clinical accessories, sports med products, taping items, lotions, and gels. These items are sold to healthcare professionals who require daily treatment tools for patient care. Dynatronics Corp targets physical medicine professionals across multiple segments, including orthopedics, pain management, and athletic training, ensuring a steady demand for its comprehensive range of therapeutic solutions. Revenue streams are derived from both direct sales of equipment and ongoing supply purchases. The company's focus on restorative products for physical therapy, rehabilitation, and athletic training positions it as a key provider for healthcare professionals seeking reliable and specialized medical tools. Its diverse product lines cater to the specific needs of practitioners in various physical medicine fields. Dynatronics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dynatronics stock

EBITDA Margin of Dynatronics is -8.44 % in 2025.

EBITDA Margin of Dynatronics changed from -6.57 % to -8.44 %, representing a 28.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Dynatronics since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Dynatronics with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Dynatronics

All Key Metrics — Dynatronics